Press Releases

Date	Title	Company
27-Nov-2023	Global In Situ Hybridization Market, witnessing a surge in cancer and genetic disorder cases, anticipates a valuation of US$ 3.9 Billion by 2032	MARKITWIRED
27-Nov-2023	Global Animal Wound Care Market sets its sights on healing, projecting an 8.7% CAGR through 2032	MARKITWIRED
27-Nov-2023	Global Pulse Oximeter Market aims for a 7.6% CAGR growth until 2032, steering health with oxygen saturation measurement devices \| FMI	MARKITWIRED
27-Nov-2023	Global Laboratory Supplies Market is set to surge to US$ 81.61 billion in sales by 2032, buoyed by escalating R&D financing for biotech and pharma \| FMI Report	MARKITWIRED
27-Nov-2023	Global At-Home Testing Market is primed for substantial growth, with a projected value of US$ 10.5 Billion by 2032, according to FMI	MARKITWIRED
27-Nov-2023	Formycon announces EMA submission for FYB203, a biosimilar candidate to Eylea® (Aflibercept)	Formycon AG
27-Nov-2023	SMART researchers pave the way for faster and safer T-cell therapy through novel contamination-detection method	SMART
27-Nov-2023	Unleashing Breakthroughs in Research: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane	Alfa Chemistry
27-Nov-2023	Alfa Chemistry: Revolutionizing Filling and Packaging Solutions for Cosmetics	Alfa Chemistry
25-Nov-2023	Biotech firm raises £1.25m for human gut model as alternative to animal testing	Aelius Biotech
24-Nov-2023	Guinea: Progress Made in HIV Care but Major Challenges Remain/ World AIDS DAY 2023	Médecins Sans Frontières/ Doctors Without Borders (MSF)
24-Nov-2023	Aptar Digital Health Expands Oncology Clinical Advisory Board	Aptar
24-Nov-2023	PAION AG cancelled guidance for financial year 2023	PAION AG
24-Nov-2023	Janssen submits application to EMA for amivantamab-based lung cancer regimen in new indication	Janssen
24-Nov-2023	European Commission Approves KAFTRIO® in Combination With Ivacaftor for the Treatment of Children With Cystic Fibrosis Ages 2 Through 5	European Commission
24-Nov-2023	Edwards Lifesciences also presented TRISCEND II six-month data for first 150 patients successfully demonstrating safety, efficacy of the EVOQUE system with improvements in quality-of-life and functional outcomes for patients	Edwards Lifesciences
24-Nov-2023	Novartis iptacopan meets primary endpoint in new rare kidney disease trial	Novartis
24-Nov-2023	Ellipses EP0031/A400 granted Orphan Drug Designation from the US Food and Drug Administration EP0031/A400, a next generation selective RET inhibitor (SRI), is currently being investigated as a treatment option for patients with RET altered tumours	Ellipses
24-Nov-2023	Break down barriers to partnerships to change the lives of millions, say NHS Confederation and the ABPI	ABPI
24-Nov-2023	M1 Kliniken AG Acquires Online Pharmacy and Secures Long-Term Procurement Advantages	M1 Kliniken AG